Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Western Blotting Market Size & Trends

The global western blotting market size was valued at USD 986.2 million in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. The rising rate of brain disorders, research initiatives in the biotech and pharma sectors, and funding by the pharmaceutical and biotechnology agencies drive market growth. Introducing advanced diagnostic technologies and the increasing number of cases of chronic diseases associated with the brain contribute to market growth. 

Biomedical and biochemical research activities are growing consistently depending on trends in the healthcare industry. As a result, western blotting has become an essential approach for protein analysis in the healthcare sector. Furthermore, improved western blotting products, such as high-sensitivity reagents, computerized structures, and software for better imaging and evaluation, underscores its efficiency, accuracy, and value.

The prevalence of HIV/AIDS in the population is one of the key factors propelling the western blotting market growth. In addition, western blotting is used in the research for Borrelia burgdorferi (Bb), which causes Lyme disorder. Furthermore, the incidences of tissue and neurological disorders, cancers, and cardiovascular issues are rising. The development of various innovations in proteomics technology and the need for high-throughput protein evaluation is anticipated to accelerate western blotting strategies. Therefore, western blotting techniques have experienced numerous technological enhancements in recent years.

Type Insights

The consumables segment dominated the market with a share of 68.1% in 2023. Consumables such as reagents, buffers, antibodies, conjugates, kits, membranes, and filter-out sheets can be customized for a single use. The consumables segment witnessed a significant demand based on the augmented sensitivity, efficiency, and specificity of the western blotting method. The development of reagents, antibodies, and kits for overall performance and simplicity has encouraged its wide adoption. Moreover, the production of specialized consumables designed for specific packages or using sophisticated blotting strategies contributes to market growth.

The instrument segment is expected to register the fastest CAGR of 6.4% in the forecast period. The continuous demand for superior and efficient devices, speedy adoption of western blotting techniques in research and diagnostic laboratories for protein evaluation, and technological advancements in devices facilitate research and development. The growing focus on improving the sensitivity, and accuracy of western blotting along with the rise in demand encourages segment growth.

Application Insights

The disease diagnostics segment dominated the western blotting market with a revenue share of 60.4% in 2023. The growing incidences of Factor V, Herplex Symptoms Virus (HSV), Hepatitis B Virus (HBV), and Lyme sickness, incidences of chronic diseases such as cancers, and autoimmune disorders account for segment growth. The demand for personalized treatments, and usage of protein biomarkers for disease diagnosis, contribute to the growth of the disease diagnostics segment. The growing adoption of western blotting in scientific laboratories for detecting disorder-specific antibodies or protein markers and the improvement of multiplexing technology for simultaneous analysis of multiple proteins in a single assay fuels segment growth.

Biomedical & biochemical research is expected to witness the fastest CAGR of 7.1% in the forecast period. Biomedical studies have increased financing from both the private and non-private sectors. The biomedical studies target to identify several illnesses, design therapy tactics, and create clinical awareness about novel medicinal drugs.

End-use Insights

The pharmaceutical and biotechnology companies segment dominated the market with a revenue share of 32.0% in 2023. The growing focus on targeted treatment, personalized medicine, and increasing investment in drug discovery contribute to the segment growth. The rapid adoption of western blotting in pre-clinical and scientific studies for the assessment of drug efficacy and safety further fuels the increased growth of pharmaceutical and biotechnology companies.

The academic & research institutes are expected to grow in the forecast period with a CAGR of 6.1%. The increasing number of research and development activities and advancements in scientific diagnostics are receiving heavy investments from key players, which is fueling the segment growth. The consistency in research activities for molecular biology, cellular biology, genetics, and biochemistry requires protein analysis techniques like western blotting. The availability of funding for research projects from government agencies, and collaborations between educational institutes and industry players for clinical research, and development drive market growth.

Regional Insights

North America western blotting market dominated the global market with a revenue share of 41.8% in 2023. The presence of manufacturing companies in the region, growing investment in proteomics studies, and a growing awareness of customized medicine encourage growth. Furthermore, North America has a well-established healthcare infrastructure and finances. This economic aid promotes the development of diagnostic procedures in scientific settings for illness analysis and control.

U.S. Western Blotting Market Trends

The U.S. western blotting market dominated North America with a revenue share of 89.4% in 2023. The U.S. market is home to several renowned biopharmaceutical groups and research institutes that conduct significant studies and research. The U.S. market has witnessed major investments in life sciences research, mainly proteomics and genomics.

Europe Western Blotting Market Trends

Europe held a significant share of the global western blotting market in 2023. A growth in the number of people suffering from HIV is one of the fundamental elements propelling the European market. Growing research and development activities, rapid adoption of personalized treatments, favorable government policies and funding, and the prominence of academic and studies institutes augment the European market growth.

Germany western blotting market is expected to grow rapidly in the forecast period due to the growing occurrence of cardiovascular diseases and cancer patients and the rise in technological improvements in the clinical sector. Companies are continuously introducing new products that enhance accuracy, efficiency, and the pace of western blotting strategies.

Western blotting market in the UK held a substantial market share in 2023. The increasing demand for protein evaluation tools driven by research activities, technological improvements, industry growth, customized medication treatment, regulatory support, and collaborative initiatives are key elements propelling the growth of the western blotting market within the UK.

Asia Pacific Western Blotting Market Trends

Asia Pacific western blotting market is expected to witness a CAGR of 7.4% in the forecast period. The biotechnology and pharmaceutical sectors in Asia Pacific are expanding swiftly due to the growing investment from both governmental and private companies. Furthermore, chronic illnesses such as cancers, diabetes, and cardiovascular disease are becoming more common in this region. This has resulted in an emphasis on personalized medicine, and focused drug treatments, with western blotting as a crucial tool within the identification and quantification of biomarkers for illness diagnosis and control.

China western blotting market is expected to witness significant growth in the forecast period due to a rise in research and development activities, healthcare expenditure, prevalence of chronic diseases, and technological advancements.

Key Western Blotting Company Insights

Some key companies in the western blotting market include Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; LI-COR, Inc.; Merck KGaA; F. Hoffmann-La Roche Ltd; Bio-Techne, and others. Organizations are growing their customer base to gain a competitive edge in the industry. Therefore, key players are following several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

• Thermo Fisher Scientific is one of the largest clinical system groups globally, imparting a vast range of products and services to numerous sectors which include pharmaceutical and biotech businesses, hospitals and clinical diagnostic labs, universities, studies establishments, and government bodies.

• Bio-Rad is globally recognized as one of the top life science agencies, presenting a huge range of products which includes equipment, software programs, consumables, reagents, and content for regions like cell biology, gene expression, protein purification, drug discovery, and food protection.

Recent Developments

• In March 2024, Wipro GE Healthcare, a prominent player in clinical diagnostics unveiled its plan to introduce 40 new products with a focus on designing and producing clinical products in India and the global market. The company plans to cover diagnostic products such as ultrasound, MRI, PET/CT, CT-scan, and patient care gadgets.

• In June 2023, Bio-Techne, a global life sciences company that offers bioactive reagents and tools for research and clinical diagnostic communities announced their plans to acquire Lunaphore, Inc. The acquisition is complementary to Bio-Techne’s leading spatial biology franchise COMET.

Western Blotting Market Report Scope

Global Western Blotting Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global western blotting market report based on type, application, end-use, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments       

    • Gel Electrophoresis Instruments

    • Blotting Systems

      • Semi-dry Blotting Instruments

      • Wet Blotting Instruments

      • Imagers             

    • Chemiluminescent Imagers

      • Fluorescent Imagers

      • Others

  • Consumables     

    • Reagents and Buffers     

    • Antibodies And Conjugates         

      • Primary Antibodies

      • Secondary Antibodies

      • Other Antibodies and Conjugates

    • Kits

    • Membranes and Filters

    • Other Consumables

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Biomedical & Biochemical Research        

  • Disease Diagnostics        

    • HIV

    • Lyme Disease

    • Hepatitis

    • Other Diseases

  • Agriculture

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Academic & Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Diagnostic Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait